Risk of Cancers According to the Use of Biological Agents in Patients With Radiographic Axial Spondyloarthritis
In patients with r-axSpA, there was no evidence of increased cancer risk with TNFis and IL-17is exposures compared with bDMARDs nonexposure, suggesting that the use of bDMARDs is safe with respect to cancer risk in patients with r-axSpA.
Authors
- Juyeon Yang (ORCID: https://orcid.org/0000-0002-7621-5150)
- Oh Chan Kwon (ORCID: https://orcid.org/0000-0001-7962-3697)
- Hye Sun Lee (ORCID: https://orcid.org/0000-0001-6328-6948)
- Min‐Chan Park (ORCID: https://orcid.org/0000-0003-1189-7637)
Institutions
- Yonsei University (KR)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1097/rhu.0000000000002188
- Citations
- 1
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.67